Society ❯ Consumer Rights ❯ Healthcare Access ❯ Drug Affordability

Public Health

White House Clinches Pfizer Pricing Deal Tied to Tariff Reprieve and $70 Billion U.S. Investment

Key terms remain confidential, leaving the effect on insured patients unclear.

White House Secures Pfizer Deal on Drug Prices With TrumpRx Discounts and $70 Billion U.S. Investment

Trump Gives Pharma CEOs 60 Days to Adopt Most-Favored-Nation Drug Pricing